241 related articles for article (PubMed ID: 32768522)
21. Tetramethylpyrazine inhibits tumor growth of lung cancer through disrupting angiogenesis via BMP/Smad/Id-1 signaling.
Jia Y; Wang Z; Zang A; Jiao S; Chen S; Fu Y
Int J Oncol; 2016 May; 48(5):2079-86. PubMed ID: 26984046
[TBL] [Abstract][Full Text] [Related]
22. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways.
Sapkota G; Knockaert M; Alarcón C; Montalvo E; Brivanlou AH; Massagué J
J Biol Chem; 2006 Dec; 281(52):40412-9. PubMed ID: 17085434
[TBL] [Abstract][Full Text] [Related]
23. The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models.
Zhao H; Cui K; Nie F; Wang L; Brandl MB; Jin G; Li F; Mao Y; Xue Z; Rodriguez A; Chang J; Wong ST
Breast Cancer Res Treat; 2012 Jan; 131(2):425-36. PubMed ID: 21394501
[TBL] [Abstract][Full Text] [Related]
24. Baicalin inhibits breast cancer development via inhibiting IĸB kinase activation in vitro and in vivo.
Gao Y; Liu H; Wang H; Hu H; He H; Gu N; Han X; Guo Q; Liu D; Cui S; Shao H; Jin C; Wu Q
Int J Oncol; 2018 Dec; 53(6):2727-2736. PubMed ID: 30320365
[TBL] [Abstract][Full Text] [Related]
25. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
26. Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis.
Liu S; González-Prieto R; Zhang M; Geurink PP; Kooij R; Iyengar PV; van Dinther M; Bos E; Zhang X; Le Dévédec SE; van de Water B; Koning RI; Zhu HJ; Mesker WE; Vertegaal ACO; Ovaa H; Zhang L; Martens JWM; Ten Dijke P
Clin Cancer Res; 2020 Mar; 26(6):1460-1473. PubMed ID: 31857432
[TBL] [Abstract][Full Text] [Related]
27. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
[No Abstract] [Full Text] [Related]
28. Epigenetic regulation of bone morphogenetic protein-6 gene expression in breast cancer cells.
Zhang M; Wang Q; Yuan W; Yang S; Wang X; Yan JD; Du J; Yin J; Gao SY; Sun BC; Zhu TH
J Steroid Biochem Mol Biol; 2007; 105(1-5):91-7. PubMed ID: 17574840
[TBL] [Abstract][Full Text] [Related]
29. HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.
Liu S; Jin K; Hui Y; Fu J; Jie C; Feng S; Reisman D; Wang Q; Fan D; Sukumar S; Chen H
Cancer Res; 2015 Feb; 75(4):709-19. PubMed ID: 25542862
[TBL] [Abstract][Full Text] [Related]
30. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
[TBL] [Abstract][Full Text] [Related]
31. Cloning and expression of a rat Smad1: regulation by TGFbeta and modulation by the Ras/MEK pathway.
Yue J; Hartsough MT; Frey RS; Frielle T; Mulder KM
J Cell Physiol; 1999 Mar; 178(3):387-96. PubMed ID: 9989785
[TBL] [Abstract][Full Text] [Related]
32. A MEK inhibitor (U0126) markedly inhibits direct liver invasion of orthotopically inoculated human gallbladder cancer cells in nude mice.
Horiuchi H; Kawamata H; Furihata T; Omotehara F; Hori H; Shinagawa Y; Ohkura Y; Tachibana M; Yamazaki T; Ajiki T; Kuroda Y; Fujimori T
J Exp Clin Cancer Res; 2004 Dec; 23(4):599-606. PubMed ID: 15743030
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of mitogen-activated protein kinase signaling pathway sensitizes breast cancer cells to endoplasmic reticulum stress-induced apoptosis.
Yang F; Tang XY; Liu H; Jiang ZW
Oncol Rep; 2016 Apr; 35(4):2113-20. PubMed ID: 26796921
[TBL] [Abstract][Full Text] [Related]
34. Cyclic tensile force up-regulates BMP-2 expression through MAP kinase and COX-2/PGE2 signaling pathways in human periodontal ligament cells.
Suzuki R; Nemoto E; Shimauchi H
Exp Cell Res; 2014 Apr; 323(1):232-241. PubMed ID: 24561081
[TBL] [Abstract][Full Text] [Related]
35. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
Ripple MO; Kalmadi S; Eastman A
Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
[TBL] [Abstract][Full Text] [Related]
37. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
[TBL] [Abstract][Full Text] [Related]
38. SMYD3 promotes the epithelial-mesenchymal transition in breast cancer.
Fenizia C; Bottino C; Corbetta S; Fittipaldi R; Floris P; Gaudenzi G; Carra S; Cotelli F; Vitale G; Caretti G
Nucleic Acids Res; 2019 Feb; 47(3):1278-1293. PubMed ID: 30544196
[TBL] [Abstract][Full Text] [Related]
39. The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
Normanno N; De Luca A; Maiello MR; Campiglio M; Napolitano M; Mancino M; Carotenuto A; Viglietto G; Menard S
J Cell Physiol; 2006 May; 207(2):420-7. PubMed ID: 16419029
[TBL] [Abstract][Full Text] [Related]
40. Phosphatidyl inositol 3-kinase (PI3K)-mTOR inhibitor PKI-402 inhibits breast cancer induced osteolysis.
Yuan G; Lian Z; Liu Q; Lin X; Xie D; Song F; Wang X; Shao S; Zhou B; Li C; Li M; Yao G
Cancer Lett; 2019 Feb; 443():135-144. PubMed ID: 30540926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
